Table 1.
Total number of patients and their COVID-19 outcomes recorded in the IMS COVID-19 data set by country and diagnosis
| All patients, n = 650 | Hospitalized | Hospitalized with invasive ventilation | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| n (%) | Died (%) | Died (%) | Recovered (%) | Unknown (%) | Total | Died (%) | Recovered (%) | Unknown (%) | Total | |
| Country | ||||||||||
| Total | 650 (100) | 222 (34.1) | 139 (31.10) | 300 (67.11) | 8 (1.79) | 447 | 73 (80.22) | 16 (17.58) | 2 (2.20) | 91 |
| Spain | 186 (28.62) | 56 (30.1) | 46 (30.26) | 105 (69.08) | 1 (0.66) | 152 | 9 (60.00) | 5 (33.33) | 1 (6.67) | 15 |
| France | 185 (28.46) | 69 (37.2) | 35 (26.52) | 97 (73.48) | 132 | 31 (83.78) | 6 (16.22) | (0.00) | 37 | |
| USA | 126 (19.38) | 31 (24.6) | 11 (21.57) | 37 (72.55) | 3 (5.88) | 51 | 17 (94.44) | 1 (5.56) | (0.00) | 18 |
| UK | 96 (14.77) | 53 (55.2) | 44 (53.66) | 37 (45.12) | 1 (1.22) | 82 | 7 (100.00) | (0.00) | (0.00) | 7 |
| Other | 57 (8.77) | 13 (22.8) | 3 (10.00) | 24 (80.00) | 3 (10.00) | 30 | 9 (64.29) | 4 (28.57) | 1 (7.14) | 14 |
| Diagnosis | ||||||||||
| Total | 646 (100) | 222 (34.3) | 139 (31.24) | 295 (66.29) | 10 (2.25) | 445 | 73 (80.22) | 16 (17.58) | 2 (2.20) | 91 |
| MM | 617 (95.51) | 212 (34.3) | 136 (31.85) | 283 (66.28) | 8 (1.87) | 427 | 67 (78.82) | 16 (18.82) | 2 (2.35) | 85 |
| MGUS/SMM | 19 (2.94) | 5 (26.3) | 1 (8.33) | 9 (75.00) | 2 (16.67) | 12 | 3 (100) | 3 | ||
| Amyloid | 10 (1.55) | 5 (50) | 2 (33.33) | 4 (66.67) | 6 | 3 (100) | 3 | |||
All patients (n = 650) refers to all of the patients including, hospitalized patients and outpatients without any exclusion, in our data set.
MGUS, monoclonal gammopathy of undetermined significance; SMM, smoldering MM; UK, United Kingdom; USA, United States of America.